Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4753960
Max Phase: Preclinical
Molecular Formula: C42H43ClFN7O7S
Molecular Weight: 844.37
Molecule Type: Unknown
Associated Items:
ID: ALA4753960
Max Phase: Preclinical
Molecular Formula: C42H43ClFN7O7S
Molecular Weight: 844.37
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1c(-c2c(-c3ccc(F)o3)sc3ncnc(O[C@H](Cc4ccccc4OCc4ccnc(N5CCOCC5)n4)C(=O)O)c23)ccc(OCCN2CCN(C)CC2)c1Cl
Standard InChI: InChI=1S/C42H43ClFN7O7S/c1-26-29(7-8-31(37(26)43)55-22-17-50-15-13-49(2)14-16-50)35-36-39(46-25-47-40(36)59-38(35)32-9-10-34(44)57-32)58-33(41(52)53)23-27-5-3-4-6-30(27)56-24-28-11-12-45-42(48-28)51-18-20-54-21-19-51/h3-12,25,33H,13-24H2,1-2H3,(H,52,53)/t33-/m1/s1
Standard InChI Key: WVHKLSAUSXZULJ-MGBGTMOVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 844.37 | Molecular Weight (Monoisotopic): 843.2617 | AlogP: 6.63 | #Rotatable Bonds: 15 |
Polar Surface Area: 148.64 | Molecular Species: ACID | HBA: 14 | HBD: 1 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.89 | CX Basic pKa: 7.65 | CX LogP: 4.21 | CX LogD: 4.07 |
Aromatic Rings: 6 | Heavy Atoms: 59 | QED Weighted: 0.12 | Np Likeness Score: -1.11 |
1. Szlavik Z,Csekei M,Paczal A,Szabo ZB,Sipos S,Radics G,Proszenyak A,Balint B,Murray J,Davidson J,Chen I,Dokurno P,Surgenor AE,Daniels ZM,Hubbard RE,Le Toumelin-Braizat G,Claperon A,Lysiak-Auvity G,Girard AM,Bruno A,Chanrion M,Colland F,Maragno AL,Demarles D,Geneste O,Kotschy A. (2020) Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor., 63 (22): [PMID:33146521] [10.1021/acs.jmedchem.0c01234] |
Source(1):